EAACI guidelines on allergen immunotherapy: Executive statement

Additional Metadata
Persistent URL	dx.doi.org/10.1111/all.13420, hdl.handle.net/1765/105904
Journal	Allergy
Grant	This work was funded by the European Commission 7th Framework Programme; grant id fp7/601763 - AN INNOVATIVE CAUSAL THERAPY FOR ALLERGY: SAFE AND RAPID INDUCTION OF AN ANTI-INFLAMMATORY IMMUNE RESPONSE USING A MUTANT HYPOALLERGEN AND VITAMIN D3 (BM4SIT)
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Muraro, A. (A.), Roberts, G, Halken, S, Agache, I. (I.), Angier, E. (E.), Fernandez Rivas, M, … Sheikh, A. (2018). EAACI guidelines on allergen immunotherapy: Executive statement. Allergy, 73(4), 739–743. doi:10.1111/all.13420

Publication